Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

NuVasive NuvaLine Mobile App

K-Number: K162647 · 2017-05-01

Decision Date2017-05-01
Product CodeLLZ
Advisory CommitteeRA
DecisionSubstantially Equivalent

Device Summary

NuVasive NuvaLine Mobile App is a medical device manufactured by Nu Vasive, Incorporated. It received FDA 510(k) clearance on 2017-05-01 under approval number K162647. The device is classified under product code LLZ. It was reviewed by the RA advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the NuVasive NuvaLine Mobile App?

NuVasive NuvaLine Mobile App is a medical device that received FDA 510(k) clearance on 2017-05-01. It is manufactured by Nu Vasive, Incorporated. The 510(k) number is K162647.

When was NuVasive NuvaLine Mobile App approved by the FDA?

NuVasive NuvaLine Mobile App received FDA 510(k) clearance on 2017-05-01, under approval number K162647.

What company makes NuVasive NuvaLine Mobile App?

NuVasive NuvaLine Mobile App is manufactured by Nu Vasive, Incorporated.

What is the FDA product code for NuVasive NuvaLine Mobile App?

The FDA product code for NuVasive NuvaLine Mobile App is LLZ.

Other Devices by Nu Vasive, Incorporated

View all 79 devices →

Related Devices (Code: LLZ)

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.